Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Breast Cancer, Breast Tumors, Cancer of Breast, Cancer of the Breast or Malignant Neoplasm of Breast
and you are
over 18
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

To determine the accuracy of NIR/US assessment of tumor vasculature and oxygen changes in predicting and monitoring early neoadjuvant treatment response compared to pathological response.

Provided treatments

  • Device: Optical Tomography Using Near Infrared Diffused Light Assisted with Ultrasound
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02891681. The sponsor of the trial is Washington University School of Medicine and it is looking for 50 volunteers for the current phase.
Official trial title:
Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment